Lilly To Appeal Invalidity Ruling For Sun In Gemzar Suit
Eli Lilly & Co. is appealing a federal court ruling that invalidated one of the patents in an infringement dispute with generic-drug maker Sun Pharmaceutical Industries Ltd. over the cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article